Cite
Methenamine hippurate to prevent recurrent urinary tract infections in older women: protocol for a randomised, placebo-controlled trial (ImpresU)
MLA
HAG Infectieziekten, et al. Methenamine Hippurate to Prevent Recurrent Urinary Tract Infections in Older Women: Protocol for a Randomised, Placebo-Controlled Trial (ImpresU). 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432120173&authtype=sso&custid=ns315887.
APA
HAG Infectieziekten, Infection & Immunity, UMC Utrecht Holding, Heltveit-Olsen, S. R., Sundvall, P. D., Gunnarsson, R., Snaebjörnsson Arnljots, E., Kowalczyk, A., Godycki-Cwirko, M., Platteel, T. N., Koning, H. A. M., Groen, W. G., Åhrén, C., Grude, N., Verheij, T. J. M., Hertogh, C. M. P. M., Lindbaek, M., & Hoye, S. (2022). Methenamine hippurate to prevent recurrent urinary tract infections in older women: protocol for a randomised, placebo-controlled trial (ImpresU).
Chicago
HAG Infectieziekten, Infection & Immunity, UMC Utrecht Holding, Silje Rebekka Heltveit-Olsen, Pär Daniel Sundvall, Ronny Gunnarsson, Egill Snaebjörnsson Arnljots, et al. 2022. “Methenamine Hippurate to Prevent Recurrent Urinary Tract Infections in Older Women: Protocol for a Randomised, Placebo-Controlled Trial (ImpresU).” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432120173&authtype=sso&custid=ns315887.